Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T14:00:35.979Z Has data issue: false hasContentIssue false

Addiction Services in Cyprus: Results of the EU Twinning Project Evaluation

Published online by Cambridge University Press:  16 April 2020

A. Agorastos
Affiliation:
Clinic for Psychiatry and Psychotherapy, Centre of Psychosocial Medicine, Hamburg, Germany
H. Zurhold
Affiliation:
Centre for Interdiscilinary Addiction Research (ZIS), UKE, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
A. Petridou
Affiliation:
PERSEAS Counselling Centre for Adolescents and Family, Cyprus Mental Health Services, Nicosia, Cyprus
C. Haasen
Affiliation:
Clinic for Psychiatry and Psychotherapy, Centre of Psychosocial Medicine, UKE, University Medical Centre Hamburg-Eppendorf, Centre for Interdisciplinary Addictio Research (ZIS), Hamburg, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In April 2007 a European twinning project started between Cyprus and Germany, in order to assist Cyprus as a new Candidate Country in the implementation and harmonisation with the European Community's legislation, by evaluating the governmental drug services in Cyprus and their coordination and promoting the improvement and introduction of new drug treatment services. A field investigation studied parameters as population in need, treatment demand and coverage, as well as high risk patterns and their trend over the last years, showing an individual place of Cyprus in the international drug ranking, with the highest prevalence of cannabis and second highest on ecstasy abuse and one of the smallest in opiates and amphetamine consumption. Nevertheless heroin remains the primary drug of abuse in persons seeking treatment, although Cyprus was until 2008 the only country of the European Union without a substitution treatment. Furthermore this project studies in detail the current availability of the governmental drug facilities, their structure and coordination as well as the legal framework in which they operate, showing a still adapting drug care system, trying to keep up with the increasing special needs of the Cypriot population, but offering the presuppositions for an efficient and good functioning drug care system in the future.

Type
S64-02
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.